Tag: Eli Lilly

Eli Lilly and Company is approaching a pivotal period marked by two significant catalysts. While the pharmaceutical giant's stock has ...

While Eli Lilly continues to post impressive prescription figures for its blockbuster weight-loss medications, a growing sense of unease is ...

Pharmaceutical giant Eli Lilly is approaching a pivotal regulatory milestone. The U.S. Food and Drug Administration (FDA) is expected to ...

The pharmaceutical landscape for weight-loss medications is transforming into a fiercely competitive battleground. Recent clinical advancements from Danish rival Novo ...

In a move that sent shockwaves through the market, global banking giant HSBC has downgraded its stance on Eli Lilly ...

To address overwhelming global demand for its blockbuster diabetes and weight-loss treatments, Eli Lilly and Company is embarking on another ...

Pharmaceutical leader Eli Lilly continues to solidify its position in the weight-loss medication sector. The company is benefiting from a ...

Pharmaceutical giant Eli Lilly issued a significant public safety alert on March 12, 2026, concerning chemically contaminated compounded versions of ...

Pharmaceutical giant Eli Lilly is making a substantial long-term commitment to China, targeting the nation as its next major growth ...

The pharmaceutical sector is bracing for potential margin compression after Novo Nordisk signaled aggressive price reductions for its blockbuster GLP-1 ...